Bvf Inc Mirum Pharmaceuticals, Inc. Transaction History
Bvf Inc
- $2.67 Billion
- Q4 2024
A detailed history of Bvf Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 2,796,513 shares of MIRM stock, worth $140 Million. This represents 4.33% of its overall portfolio holdings.
Number of Shares
2,796,513
Previous 3,075,907
9.08%
Holding current value
$140 Million
Previous $120 Million
3.61%
% of portfolio
4.33%
Previous 3.81%
Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
208Shares Held
54MCall Options Held
64.1KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$329 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$229 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$162 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$130 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$121 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.84B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...